MedPath

Efficacy of ramelteon on sleep disturbance and restlessness in acute stroke

Not Applicable
Conditions
stroke
Registration Number
JPRN-UMIN000012755
Lead Sponsor
Yokohama Sakae Kyosai Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients taking ramelteon at the time of admission 2.Patients with contraindication for ramelteon (known hypersensitivity to remelteon, a history of severe liver/hepatic dysfunction, patients taking fluvoxamine maleate) 3.Patients who were not able to take drug both orally and through the tube

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Richmond agitation sedation scale two weeks after intervention
Secondary Outcome Measures
NameTimeMethod
sleep condition/ insomnia/ daytime somnolence/ administration of sedative medication, psychotropic medication and sleep medication except for ramelteon/ body restraint/ fall/ modified Rankin Scale/ adverse events
© Copyright 2025. All Rights Reserved by MedPath